Business description not available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 33M | 0 | 0 | 0 |
| Net Income | -74M | -74M | -43M | -60M | -55M | -39M |
| EPS | $-1.56 | $-1.56 | $-1.17 | $-1.73 | $-1.59 | $-1.58 |
| Free Cash Flow | -22M | -22M | -14M | -39M | -36M | -32M |
| ROIC | -80.1% | -80.1% | -22.5% | -61.7% | -40.8% | -21.5% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | - | - | - | 1.41 | 0.63 |
| Dividends/Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -74M | -74M | -29M | -49M | -62M | -42M |
| Operating Margin | 0.0% | - | -89.1% | - | - | - |
| ROE | 0.0% | - | - | - | -175.4% | -47.7% |
| Shares Outstanding | 47M | 47M | 37M | 35M | 35M | 24M |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0 | 0 | 0 | 33M | 0 | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | -28M | -36M | -34M | -42M | -44M | -44M |
| SG&A | -17M | -23M | -19M | -24M | -22M | -22M |
| EBIT | -42M | -62M | -49M | -29M | -74M | -74M |
| Op. Margin | N/A | N/A | N/A | -89.1% | N/A | 0.0% |
| Net Income | -39M | -55M | -60M | -43M | -74M | -74M |
| Net Margin | N/A | N/A | N/A | -132.1% | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | -21.5% | -40.8% | -61.7% | -22.5% | -80.1% | -80.1% |
| ROE | -47.7% | -175.4% | N/A | N/A | N/A | 0.0% |
| ROA | -25.1% | -46.2% | -95.4% | -42.3% | -101.1% | -101.1% |
| Cash Flow | ||||||
| Op. Cash Flow | -32M | -35M | -39M | -14M | -21M | -21M |
| Free Cash Flow | -32M | -36M | -39M | -14M | -22M | -22M |
| Owner Earnings | -37M | -41M | -44M | -19M | -28M | -28M |
| CapEx | 110K | 269K | 97K | 356K | 914K | 914K |
| Maint. CapEx | 2.0M | 1.8M | 1.6M | 1.6M | 1.8M | 1.8M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 2.0M | 1.8M | 1.6M | 1.6M | 1.8M | 1.8M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 31K | 7K | 27K | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | 3.4M | 3.8M | 3.3M | 3.5M | 4.6M | 4.6M |
| Debt Repayment | 287K | 3.3M | 3.8M | 3.2M | 3.3M | 3.3M |
| Balance Sheet | ||||||
| Net Debt | -86M | -54M | 7.6M | -32M | -4.1M | -54M |
| Cash & Equiv. | 137M | 99M | 44M | 82M | 54M | 54M |
| Long-Term Debt | 51M | 45M | 51M | 49M | 50M | 50M |
| Debt/Equity | 0.63 | 1.41 | N/A | N/A | N/A | 0.00 |
| Interest Coverage | N/A | -67.4 | -3.4 | -1.8 | -9.1 | -9.1 |
| Equity | 81M | 32M | -28M | -2.0M | -71M | -71M |
| Total Assets | 154M | 120M | 63M | 102M | 73M | 73M |
| Total Liabilities | 73M | 88M | 0 | 0 | 0 | 0 |
| Intangibles | 0 | 0 | 0 | 9K | 8K | 8K |
| Retained Earnings | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital | 122M | 66M | 15M | 41M | 2.7M | 2.7M |
| Current Assets | 144M | 110M | 55M | 95M | 66M | 66M |
| Current Liabilities | 22M | 43M | 40M | 54M | 64M | 64M |
| Per Share Data | ||||||
| EPS | -1.58 | -1.59 | -1.73 | -1.17 | -1.56 | -1.56 |
| Owner EPS | -1.52 | -1.17 | -1.26 | -0.51 | -0.58 | -0.58 |
| Book Value | 3.32 | 0.91 | -0.82 | -0.05 | -1.50 | -1.50 |
| Cash Flow/Share | -1.50 | -1.54 | -1.68 | -1.13 | -1.52 | -1.52 |
| Dividends/Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Out. | 24.3M | 34.8M | 34.8M | 36.8M | 47.3M | 47.3M |
| Valuation | ||||||
| P/E Ratio | -11.5 | -5.0 | -2.3 | -6.3 | -2.1 | -16.9 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 5.5 | 8.8 | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | 8.3 | N/A | N/A |
| FCF Yield | -7.2% | -12.8% | -28.5% | -5.2% | -14.6% | -1.8% |
| Market Cap | 442M | 277M | 137M | 270M | 151M | 1.2B |
| Avg. Price | 8.83 | 14.15 | 5.30 | 5.77 | 5.47 | 26.36 |
| Year-End Price | 18.18 | 7.95 | 3.95 | 7.34 | 3.19 | 26.36 |
NANOBIOTIX passes 0 of 9 quality checks, indicating weak fundamentals.
NANOBIOTIX (NANO-PA) has a 5-year average return on invested capital (ROIC) of -45.3%. This is below average and may indicate limited pricing power.
NANOBIOTIX (NANO-PA) has a market capitalization of $1.2B. It is classified as a small-cap stock.
NANOBIOTIX (NANO-PA) does not currently pay a regular dividend.
NANOBIOTIX (NANO-PA) generated $-22 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
NANOBIOTIX (NANO-PA) reported earnings per share (EPS) of $-1.56 in its most recent fiscal year.
The Ledger Terminal provides 5 years of financial data for NANOBIOTIX (NANO-PA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
NANOBIOTIX (NANO-PA) has a book value per share of $-1.50, based on its most recent annual SEC filing.